Although the oral administration route can be regarded as the most convenient one, most therapeutic peptides and proteins are available only as injections. This is due to the low bioavailability of orally administered peptide drugs, which is caused by a number of barriers, including the enzymatic barrier 1) and the permeation barrier.2) As oral peptide delivery is highly demanded by patients, various approaches have been developed in recent years to overcome these barriers and to achieve sufficient bioavailability after oral administration. One promising approach is the coating of liposomes with bioadhesive polymers such as chitosan or carbopol (CP). It has been demonstrated that such delivery systems exhibit increased bioadhesive properties and are capable of improving and prolonging the pharmacological effect of incorporated peptides, such as calcitonin or insulin.3) Another approach is based on the specific bioadhesive properties of lectins. Wheat germ agglutinin (WGA) from Triticum vulgaris is a non-toxic glycoprotein which can specifically bind to Nacetyl-D-glucosamine. 4) This sugar is present on intestinal cells as well as in the intestinal mucus. 5) Recently, it was demonstrated that lectin-conjugated polylactic-co-glycolic acid (PLGA) nanoparticles display increased intestinal bioadhesion and furthermore increase the oral bioavailability of peptide drugs. 6,7) It was the aim of the study to (1) synthesize a novel polymer-lectin conjugate by covalently attaching WGA to carbopol, (2) investigate if the covalent attachment of WGA does decrease or abolish the binding activity of WGA to N-acetyl-D-glucosamine, (3) prepare CP-lectin coated liposomes, and (4) evaluate these coated liposomes concerning intestinal bioadhesion and effect on the oral absorption of incorporated calcitonin.
Results and DiscussionThe novel CP-lectin conjugate was synthesized by covalently attaching the amino groups of WGA to the carbodiimide-activated carboxylic groups of carbopol (Fig. 1). Using a spectrophotometric method, the amount of WGA in the purified polymer-lectin conjugate was determined to be 11.79Ϯ 0.8% (mg lectin/100 mg of CP-lectin). To investigate, whether the covalently bound WGA was still capable of binding to N-acetyl-D-glucosamine, a haemagglutination test was performed. N-acetyl-D-glucosamine is, among others, present on the surface of erythrocytes. Therefore, erythrocytes agglutinate in the presence of WGA. Results of this study are shown in Fig. 2. Agglutination was clearly observed in the presence of unbound WGA as well as in the presence of CP-lectin. Contrary, no agglutination was observed in presence of unmodified CP. These results reveal that the novel CP-lectin conjugate is capable of binding to its substrate. Moreover, the comparison of the agglutination behaviour of various concentrations of unbound WGA and CPlectin supports the calculations concerning the amount of WGA in the CP-lectin conjugate gained in the spectrophotometric studies. Next, we investigated if positively charged liposomes can be coated...